Clinical Trial Update: A Study of TCD601 in de Novo Renal Transplant Recipients [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial of TCD601 in de novo renal transplant recipients, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• TCD601

Snippet

Sponsor: ITB-Med LLC | Conditions: Renal Transplantation | Phase 2 | Status: ACTIVE_NOT_RECRUITING